Biological Age: What It Is, How to Measure It, and What Actually Moves It

Co-authored by David Furman, PhD. Director of the Stanford 1000 Immunomes Project and Professor at the Buck Institute for Research on Aging.

Biological age is an estimate of how old your body is at the cellular and molecular level, independent of your birthday. Two 45-year-olds can differ by a decade or more in their rate of cellular decline, disease risk, and functional capacity. Understanding and tracking biological age is one of the most actionable steps in longevity science, because unlike chronological age, biological age responds to intervention.

[[VIDEO]]

Why Biological Age Matters More Than Your Birthday

Chronological age is simple: it counts years since birth. Biological age is more complex and more useful. It reflects the cumulative state of your cells, tissues, and organ systems, shaped by genetics, environment, lifestyle, and the interventions you choose.

Research consistently shows that people of the same chronological age can diverge significantly in biological aging. A landmark 2015 study from Duke University tracked 954 people born in the same year and found that by age 38, their biological ages ranged from under 30 to nearly 60. Some participants were aging at a rate of nearly three biological years per calendar year, while others were aging slower than the clock (Belsky et al., PNAS 2015).

This matters because biological age predicts outcomes that chronological age cannot. Accelerated biological aging is associated with earlier onset of cardiovascular disease, metabolic dysfunction, cognitive decline, and reduced physical function. Conversely, people whose biological age is younger than their chronological age tend to have better cardiometabolic profiles, stronger immune function, and longer healthspan.

Biological Age and Healthspan: The Connection That Matters

Healthspan is the period of life spent in good health, free from chronic disease and functional decline. It is distinct from lifespan, which simply counts total years alive. The gap between the two is where most suffering concentrates: the years spent managing chronic conditions, losing independence, and declining in cognitive and physical capacity.

Biological age is the best available proxy for where you sit on the healthspan curve. Someone with a biological age 10 years younger than their chronological age is not just "aging well" in an abstract sense. They are statistically more likely to maintain muscle mass, cognitive sharpness, metabolic flexibility, and immune resilience for longer.

The reverse is equally true. Accelerated biological aging, measured through epigenetic clocks and biomarker panels, correlates with earlier onset of the diseases that compress healthspan: type 2 diabetes, cardiovascular disease, neurodegeneration, and immune dysfunction. The DunedinPACE analysis found that faster biological aging predicted incident disease across multiple organ systems, even after adjusting for traditional risk factors (Belsky et al., eLife 2022).

This is why biological age is not just a curiosity metric. It is a leading indicator of healthspan trajectory. If you can slow or stabilize your rate of biological aging, you are extending the portion of your life spent healthy and functional.

How Biological Age Is Measured: The Major Tools

Several technologies exist for estimating biological age, each with different strengths and limitations. Understanding what each measures helps you interpret results without overreacting or underreacting.

Epigenetic Clocks (DNA Methylation)

Epigenetic clocks are the most widely used biological age measurement tools. They analyze patterns of DNA methylation, chemical tags on your genome that change predictably with age and affect which genes are active without altering the DNA sequence itself.

The field has evolved through three generations. First-generation clocks like the Horvath Clock (2013) and Hannum Clock (2013) were trained to predict chronological age from methylation patterns across hundreds of CpG sites. They demonstrated that aging leaves measurable molecular signatures, but they were primarily age estimators, not health-risk predictors.

Second-generation clocks made an important leap. PhenoAge (Levine et al., 2018) incorporated clinical biomarkers alongside methylation data, connecting the clock to morbidity and mortality risk rather than just calendar time. GrimAge (Lu et al., 2019) added methylation-based surrogates for plasma proteins and smoking history, and has become one of the strongest single predictors of all-cause mortality available in any clinical or research context.

The newest class is pace-of-aging clocks. DunedinPACE (Belsky et al., eLife 2022) measures not "how old are you biologically" but "how fast are you aging right now." Trained on longitudinal data tracking organ-system decline over time, it captures rate rather than position. This makes it the most intervention-sensitive clock currently available, and the most useful for monitoring whether a longevity protocol is actually working.

Blood Biomarker Panels

Composite biomarker panels use standard blood tests (glucose, CRP, lipid panels, liver enzymes, kidney function markers, complete blood count) to estimate biological age through algorithmic scoring. Companies like InsideTracker and Levine's PhenoAge algorithm use this approach.

The advantage is accessibility and cost: these use routine lab work. The limitation is that blood biomarkers fluctuate with acute conditions, stress, diet, and hydration, which introduces noise into the measurement.

Telomere Length

Telomere testing measures the protective caps on your chromosomes, which shorten with each cell division. While telomere shortening is a real hallmark of aging, single-point telomere measurements have proven less predictive of health outcomes than epigenetic clocks. The measurement variance is high, and telomere length is influenced by genetics, making it harder to isolate the effects of lifestyle or supplementation.

Proteomic and Multi-Omics Clocks

Emerging approaches use protein signatures (proteomics) or combine multiple data layers (multi-omics) for more comprehensive biological age estimation. Because proteins sit closer to functional physiology than DNA methylation alone, proteomic clocks may eventually capture systemic aging states more completely. This is an active area of research but not yet widely available for consumer use.

Expert Perspective: David Furman, PhD

Biological age measurement has become a central lens for validating aging interventions, and the evolution from first-generation chronological predictors to pace-of-aging tools like DunedinPACE represents a genuine paradigm improvement. In our work with the Stanford 1000 Immunomes Project, we see that immune system aging, what we call the iAge inflammatory clock, correlates strongly with epigenetic biological age but captures additional dimensions of systemic decline that methylation alone misses. For consumers evaluating longevity protocols, I recommend establishing baseline biological age measurements across multiple modalities and tracking changes over 6 to 12 months, while understanding that no single number captures the full complexity of how you are aging.

David Furman, PhD, Director, Stanford 1000 Immunomes Project. Professor, Buck Institute for Research on Aging.

What Actually Moves Biological Age? The Evidence Hierarchy

Not everything marketed as "age-reversing" actually changes biological age in measurable, reproducible ways. The evidence falls into a clear hierarchy.

Tier 1: Lifestyle Interventions (Strongest Evidence)

The strongest evidence for shifting biological age comes from lifestyle factors. Exercise, sleep quality, stress management, and nutrition have all demonstrated measurable effects on epigenetic clocks and pace-of-aging metrics.

A 2021 pilot randomized controlled trial in 43 healthy men aged 50 to 72 found that an 8-week lifestyle program combining diet, exercise, sleep optimization, and stress management was associated with roughly 3.2 years lower biological age versus controls on the Horvath clock (Fitzgerald et al., Aging 2021). Aerobic fitness, measured by VO2 max, is one of the single strongest predictors of how far biological age deviates from chronological age.

A larger and longer trial pointed the same direction using a different clock. CALERIE, a 2-year randomized controlled trial in 220 healthy adults, assigned participants to 25% caloric restriction or a normal diet. Caloric restriction slowed the pace of aging by about 2 to 3% on DunedinPACE, though it did not significantly move the static PhenoAge or GrimAge clocks (Waziry et al., Nature Aging 2023). The effect is small, but in validation studies a 2 to 3% slower pace corresponds to roughly a 10 to 15% lower mortality risk, comparable to quitting smoking. It is the first randomized trial to show a lifestyle intervention can slow a pace-of-aging clock in humans, and it is part of why DunedinPACE is the most intervention-sensitive measure available.

Sleep quality also shows consistent associations. Poor sleep accelerates epigenetic aging, while restorative sleep supports the cellular repair processes that keep biological age in check.

Tier 2: Targeted Compounds (Moderate Evidence)

Several compounds have shown preliminary evidence for slowing biological aging markers in human or strong preclinical studies.

Urolithin A has strong clinical evidence (Andreux et al., Nature Metabolism 2019) for supporting mitochondrial function through mitophagy activation. Mitochondrial dysfunction is one of the 12 hallmarks of aging, and mitochondrial health directly affects the cellular energy production that epigenetic maintenance depends on.

NMN supports NAD+ levels, which decline with age. NAD+ is required for sirtuin activity, DNA repair enzymes (PARPs), and mitochondrial function. Multiple human trials have confirmed that NMN supplementation raises blood NAD+ levels, though the downstream effects on biological age clocks are still being characterized.

Calcium alpha-ketoglutarate (Ca-AKG) has generated interest because of its role in the TCA cycle and its connection to epigenetic enzymes. A 2021 study by Demidenko and colleagues tested Rejuvant, a calcium alpha-ketoglutarate formulation with an added vitamin (vitamin A for men, vitamin D for women), and measured an average 8-year reduction in biological age over an average of 7 months on a DNA methylation test. That headline is attention-grabbing, but the study has significant limitations that require careful interpretation.

The Demidenko Study: Promise and Caveats

The Demidenko 2021 study analyzed 42 individuals who took Rejuvant (1 gram of calcium alpha-ketoglutarate per dose, plus vitamin A for men or vitamin D for women) for an average of 7 months. Biological age was measured using the TruAge DNA methylation test at baseline and after the intervention period. The average reduction was approximately 8 years.

Before accepting this at face value, five limitations matter.

First, the study used an open-label design with no placebo control. In a double-blind trial, neither participants nor researchers know who received the active compound. This is the gold standard because it eliminates expectation bias. The Demidenko study did not use blinding; participants knew they were taking a longevity supplement, and researchers knew they were administering one. This introduces significant potential for placebo and observer effects.

Second, the sample size was small (n=42), and assignment was not randomized. Small, non-randomized studies can produce dramatic results that do not replicate in larger, controlled populations. Statistical power is limited, and outlier effects are magnified.

Third, Rejuvant is not Ca-AKG in isolation. The men's formula also delivered vitamin A and calcium, the women's formula used vitamin D, and the timed-release delivery differs from generic Ca-AKG. The observed effect could have come from the calcium salt, the added vitamin, the delivery system, the combination, or lifestyle changes participants made after enrolling in a "longevity study."

Fourth, no independent research group has replicated the findings. In science, replication is how preliminary results become established evidence. Without it, the Demidenko study remains a single data point.

Fifth, epigenetic clocks carry an inherent uncertainty of roughly 3 to 5 years. An 8-year shift, while notable, sits in a range where measurement noise could contribute meaningfully to the result.

The fair assessment: the Demidenko study hints at genuine metabolic benefit from the Rejuvant formulation. It does not prove that Ca-AKG alone reduces biological age. It is a promising signal that requires validation through larger, placebo-controlled, independently replicated trials.

Tier 3: Emerging Research (Early Evidence)

Several other interventions are being studied for effects on biological age, including rapamycin (the PEARL trial explored this at low intermittent doses), senolytics like fisetin and dasatinib plus quercetin, and various caloric restriction mimetics. Most of this evidence is preclinical or from small pilot studies.

How Protocol 01 Approaches Biological Age

Protocol 01 is designed around the 12 hallmarks of aging framework, targeting the upstream biological processes that drive biological age acceleration. Rather than claiming to "reverse" biological age, the protocol supports the cellular systems that epigenetic clocks measure.

Ca-AKG (1,000 mg daily) provides direct TCA cycle substrate support. Your mitochondria produce AKG constantly as an intermediate step in energy production, and AKG is also a required cofactor for TET enzymes and Jumonji-domain demethylases, the enzymes that regulate DNA methylation and histone modification. In other words, the epigenetic processes that biological clocks measure depend on adequate AKG availability.

NMN (350 mg daily) supports NAD+ levels, which are required for sirtuin-mediated deacetylation of histones, an epigenetic maintenance process. Urolithin A (500 mg daily) supports mitophagy, clearing dysfunctional mitochondria that would otherwise generate oxidative stress and inflammatory signaling, both of which accelerate epigenetic aging.

The methylation support stack (5-MTHF, methylcobalamin B12, vitamin B6) provides the methyl donors and cofactors that the methylation cycle requires. This is particularly relevant for individuals with MTHFR gene variants that impair folate metabolism, a common polymorphism carried by a sizable share of the population.

The monthly senolytic pulse (fisetin, isoquercetin, bromelain, piperine, fenugreek galactomannan) targets senescent cells, which produce the SASP inflammatory signaling that accelerates epigenetic aging in surrounding tissue.

How to Track Your Own Biological Age

If you want to measure your biological age, a few practical guidelines apply.

Choose a second-generation or pace-of-aging clock. DunedinPACE or GrimAge-based tests provide more health-relevant information than first-generation chronological-age predictors. Several consumer testing companies now offer these, typically through blood or saliva samples analyzed for DNA methylation patterns.

Test at baseline before starting any new protocol, then retest at 6 to 12 months. A single measurement is a snapshot; trend data over time is far more informative. Biological age can fluctuate with acute illness, stress, sleep debt, and other transient factors, so avoid testing during periods of unusual physiological stress.

Complement clock results with functional biomarkers. Blood glucose regulation (HbA1c, fasting insulin), inflammatory markers (hs-CRP), lipid panels, liver and kidney function, and body composition provide context that a methylation clock alone cannot. Grip strength, VO2 max, and balance testing add functional performance data.

Do not over-interpret a single result. Epigenetic clocks have measurement uncertainty of roughly 3 to 5 years. A result showing you are "5 years younger than your age" is encouraging but not definitive. A consistent trend across multiple measurements is more meaningful than any single number.

What We Can and Cannot Claim

Responsible communication about biological age requires precision. Protocol 01 can make the following structure/function claims:

• Supports cellular energy metabolism through TCA cycle substrate provision (Ca-AKG)
• Supports mitochondrial function and mitophagy (Urolithin A, NMN)
• Supports methylation cycle cofactor availability (5-MTHF, B12, B6)
• Provides ingredients studied for their effects on cellular aging biomarkers

What we cannot claim: "reverses biological age," "makes you 8 years younger," "clinically proven to reduce biological age," or "extends lifespan." These statements exceed the current evidence. The Demidenko study is a single, uncontrolled trial with a mixed formulation. Biological age is an emerging field where measurement tools are still being validated and standardized.

Frequently Asked Questions

What is the difference between chronological age and biological age?

Chronological age counts years since birth. Biological age estimates how old your cells and tissues are based on molecular markers, primarily DNA methylation patterns. Two people born on the same day can have biological ages that differ by 10 to 20 years depending on genetics, lifestyle, environment, and interventions.

Which biological age test should I take?

For the most actionable information, choose a test based on a second-generation clock (GrimAge or PhenoAge) or a pace-of-aging clock (DunedinPACE). These correlate more strongly with health outcomes than first-generation chronological-age predictors. Blood-based tests are generally more accurate than saliva-based options.

Can you reverse biological age?

Some evidence suggests biological age markers can move in the right direction. The strongest signal comes from lifestyle: a 2021 pilot randomized trial found that an 8-week diet and lifestyle program lowered Horvath clock age by about 3.2 years versus controls. Supplement evidence is earlier and less certain. No intervention has yet been shown in large, placebo-controlled, independently replicated trials to durably reverse biological age, so treat dramatic "age reversal" claims with caution.

Can supplements actually change biological age?

The evidence is preliminary. Some compounds have shown effects on biological age markers in small studies (the Demidenko 2021 Ca-AKG study being the most cited example), but no large, placebo-controlled, independently replicated trial has definitively proven that any supplement reduces biological age. We treat targeted supplementation as a complementary layer that builds on a strong lifestyle foundation, not a substitute for it.

How often should I test my biological age?

Once at baseline, then every 6 to 12 months. More frequent testing introduces noise from acute fluctuations (illness, stress, sleep disruption). Trend data over time is more meaningful than any single measurement.

Why does Protocol 01 include Ca-AKG if the evidence for biological age reversal is uncertain?

Ca-AKG is included not as a biological age reversal agent but as a TCA cycle substrate that supports mitochondrial energy production and provides cofactors for the epigenetic enzymes (TET enzymes, Jumonji-domain demethylases) that maintain DNA methylation patterns. The 1,000 mg daily dose is consistent with the research literature. The Demidenko study is a promising signal, but the inclusion rationale is mechanistic, not based on a single clinical headline.

Is biological age testing covered by insurance?

Currently, most biological age testing is consumer-pay. Standard blood panels that contribute to biomarker-based estimates (CBC, metabolic panel, lipid panel, HbA1c, hs-CRP) are typically covered through routine healthcare. Epigenetic clock testing through consumer companies ranges from roughly $200 to $500 per test.

Key Takeaways

• Biological age measures how old your body is at the molecular level, independent of your birthday. It is a stronger predictor of healthspan trajectory than chronological age.
• Epigenetic clocks have evolved from simple age estimators to health-relevant tools. Second-generation clocks (GrimAge, PhenoAge) and pace-of-aging clocks (DunedinPACE) are the most informative options available.
• Lifestyle interventions (exercise, sleep, nutrition, stress management) have the strongest evidence for influencing biological age. Targeted supplementation is a complementary layer, not a replacement.
• The Demidenko 2021 Ca-AKG study showed a promising signal (approximately 8-year reduction) but has significant limitations: no placebo control, small non-randomized sample, mixed formulation, and no independent replication.
• Track biological age at baseline and again at 6 to 12 months. Combine epigenetic clock data with functional biomarkers for a fuller picture, and avoid over-interpreting any single result.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any new supplement protocol.

About the Author

Dr. David Furman is the Director of the Stanford 1000 Immunomes Project and a Professor at the Buck Institute for Research on Aging, two of the most respected institutions in longevity science. A pioneer of inflammaging research, he developed the iAge clock, an AI-driven biomarker that measures inflammatory aging and predicts age-related disease years before symptoms emerge. His work sits at the center of a defining question in modern longevity science: how the immune system ages, and what that means for how long we live well.